Fintel reports that on May 3, 2024, Wells Fargo initiated coverage of Kiniksa Pharmaceuticals (NasdaqGS:KNSA) with a Overweight recommendation.
Fintel reports that on May 2, 2024, Exane BNP Paribas initiated coverage of Meta Platforms (NasdaqGS:META) with a Underperform recommendation.
Fintel reports that on April 29, 2024, Leerink Partners initiated coverage of Immunocore Holdings plc - Depositary Receipt () (NasdaqGS:IMCR) with a Outperform recommendation.
Fintel reports that on April 29, 2024, HC Wainwright & Co. initiated coverage of Ovid Therapeutics (NasdaqGS:OVID) with a Buy recommendation.
Fintel reports that on April 29, 2024, Noble Capital Markets initiated coverage of SKYX Platforms (NasdaqCM:SKYX) with a Outperform recommendation.
Fintel reports that on April 26, 2024, DA Davidson initiated coverage of Napco Security Technologies (NasdaqGS:NSSC) with a Buy recommendation.
Fintel reports that on April 25, 2024, HC Wainwright & Co. initiated coverage of Processa Pharmaceuticals (NasdaqCM:PCSA) with a Buy recommendation.
Fintel reports that on April 25, 2024, Craig-Hallum initiated coverage of Red Robin Gourmet Burgers (NasdaqGS:RRGB) with a Buy recommendation.
Fintel reports that on April 22, 2024, B of A Securities initiated coverage of Madrigal Pharmaceuticals (NasdaqGS:MDGL) with a Underperform recommendation.
Fintel reports that on April 22, 2024, Oppenheimer initiated coverage of Kymera Therapeutics (NasdaqGM:KYMR) with a Outperform recommendation.
Fintel reports that on April 19, 2024, Small Cap Consumer Research initiated coverage of a.k.a. Brands Holding (NYSE:AKA) with a Buy recommendation.
Fintel reports that on April 17, 2024, Maxim Group initiated coverage of Amazon.com (NasdaqGS:AMZN) with a Buy recommendation. Analyst Price Forecast Suggests 18.22% Upside